Detalhe da pesquisa
1.
Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti.
Clin Infect Dis
; 69(4): 717-719, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698688
2.
Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
PLoS Med
; 14(7): e1002357, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28742880
3.
Successful outcomes for patients with drug-resistant tuberculosis despite civil unrest and COVID-19 in Haiti.
PLOS Glob Public Health
; 3(9): e0002356, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698996
4.
Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis.
Open Forum Infect Dis
; 9(9): ofac440, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172057
5.
Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti.
Am J Trop Med Hyg
; 100(2): 392-398, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30594266
6.
Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 18(4): 257-265, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519619